CLINICAL_TRIALS
trial_result
· 2025-12-05
Clinical Trial Update: A Clinical Study of MR13A9 in Hemodialysis Patients With Pruritus. [Phase 2]
Summary
Phase 2 clinical trial of MR13A9 in hemodialysis patients with uremic pruritus has completed, and results were posted on December 5, 2025.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Kissei Pharmaceutical Co., Ltd. | Conditions: Uremic Pruritus | Phase 2 | Status: COMPLETED | Results posted: 2025-12-05